2003
DOI: 10.1046/j.1365-2222.2003.01770.x
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin‐1β and interleukin‐1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non‐asthmatic subjects

Abstract: These results demonstrate differences between non-asthmatic and asthmatic subjects in the basal levels of nasal cytokines and their inhibitors, and in the effect of experimental RV-infection on these levels. The results indicate that RV may enhance inflammation more markedly in asthmatics, and suggest that this may in part be explained by lower IL-1ra levels. In addition, the observation that budesonide-treatment may result in higher nasal IL-1ra levels supports the hypothesis that steroids act in part by incr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
47
0
2

Year Published

2005
2005
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(53 citation statements)
references
References 14 publications
4
47
0
2
Order By: Relevance
“…For example, after inoculation with the virus, nasal lavage levels of IL-8 and the proinflammatory mediator IL-1b were increased in asthmatic patients. 27 In this study, a small increase in the anti-inflammatory marker IL-1 receptor antagonist (IL-1ra), a competitive inhibitor of IL-1, also occurred in asthmatic subjects treated with budesonide, whereas lower levels were found in these patients at baseline. These findings suggest that RV might be able to alter the proinflammatory/antiinflammatory balance of IL-1b/IL-1ra toward inflammation more markedly in people with existing and active asthma.…”
Section: How Does Rv Modulate Inflammatory Mediators Of Epithelial Cementioning
confidence: 68%
“…For example, after inoculation with the virus, nasal lavage levels of IL-8 and the proinflammatory mediator IL-1b were increased in asthmatic patients. 27 In this study, a small increase in the anti-inflammatory marker IL-1 receptor antagonist (IL-1ra), a competitive inhibitor of IL-1, also occurred in asthmatic subjects treated with budesonide, whereas lower levels were found in these patients at baseline. These findings suggest that RV might be able to alter the proinflammatory/antiinflammatory balance of IL-1b/IL-1ra toward inflammation more markedly in people with existing and active asthma.…”
Section: How Does Rv Modulate Inflammatory Mediators Of Epithelial Cementioning
confidence: 68%
“…The sample size was estimated based on cytokine production in previous studies with RV16,26 showing variation of 20% after RV16 infection in patients with allergic asthma. Fourteen individuals per group were needed to detect an effect of 25% with two-sided significance of p=0.05 and a power of 90%.…”
Section: Methodsmentioning
confidence: 99%
“…There is a wealth of data to suggest that IL-1␤ levels are enhanced within the airways of patients with COPD or asthma, with further increases detected during acute exacerbations (7,10,59). Furthermore, epithelial and monocytic cells (PBMCs and alveolar macrophages) taken from such patients respond to inflammatory stimuli with greater IL-1␤ production (21,48,68).…”
mentioning
confidence: 99%